Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes.
about
Integrating systems biology sources illuminates drug action.Gender differences in insulin resistance, body composition, and energy balance.Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status.Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.Menopause care for obese and diabetic women.Relation between hormone replacement therapy and ischaemic heart disease in women: prospective observational studyRisks and benefits of hormone replacement therapy: the evidence speaks.Estrogens and the diabetic kidneySex hormones, insulin sensitivity, and diabetes mellitus.Menopause and risk of diabetes in the Diabetes Prevention ProgramMeta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.Impact of ovarian function on cardiovascular health in women: focus on hypertension.Hepatic overexpression of steroid sulfatase ameliorates mouse models of obesity and type 2 diabetes through sex-specific mechanisms.Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications.Adjusting the 17β-Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy.Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes.Factors associated with menstrual cycle irregularity and menopause.The benefits of oestrogens on postprandial lipid metabolism are lost in post-menopausal women with Type 2 diabetes.
P2860
Q33645618-6BB48DFB-BB29-41ED-BC19-53B9D89D618EQ34013754-7E48DD50-69A4-470F-A4DF-767C1A657A49Q34163992-0F4557C0-94F8-4F44-88E0-6E61A3D4B25BQ34328229-47E145EB-1F7A-4D8A-AA89-58F2E1487A8BQ34608171-A5393775-8CC9-43B5-8470-140BE7E57D68Q34739277-CFF686FD-9AE9-4706-B6FE-5F49137A3932Q34899934-D581EEE6-7E06-438C-9D04-4552A8D699B5Q35228627-6500B25B-CFE5-4165-BB4D-BBFCB729BB6BQ35757562-1E0538C8-3395-40C8-9AAC-C3E09FF1AB09Q36407356-2056081B-7D63-4825-B856-6F25966B980FQ36570589-FD3D1902-77B8-4D02-B173-CAF81840F30BQ37538095-11A8679C-5BA0-440C-A358-7B07C55E07D6Q37653220-F45CB35E-2979-4836-821B-00E33B0EB662Q39190439-C9442FB8-F99A-42EC-9B9B-B9079EB22057Q41645541-6C733E7C-8E31-4DC9-AD8A-3CCDFE24D806Q44700353-2E930772-45D4-4F51-AD2E-957EDDE3FE3AQ48096281-ED1840B3-F33E-4C44-8905-79753455EA02Q51494719-265A2A9F-3F12-412D-845C-72CC7A0F4880
P2860
Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Conjugated equine estrogen imp ...... al women with type 2 diabetes.
@ast
Conjugated equine estrogen imp ...... al women with type 2 diabetes.
@en
type
label
Conjugated equine estrogen imp ...... al women with type 2 diabetes.
@ast
Conjugated equine estrogen imp ...... al women with type 2 diabetes.
@en
prefLabel
Conjugated equine estrogen imp ...... al women with type 2 diabetes.
@ast
Conjugated equine estrogen imp ...... al women with type 2 diabetes.
@en
P2093
P356
P1476
Conjugated equine estrogen imp ...... al women with type 2 diabetes.
@en
P2093
P356
10.1210/JC.86.1.48
P407
P577
2001-01-01T00:00:00Z